OasisLMS

Implementing the 2026 Dyslipidemia Guidelines: From Risk Stratification to Personalized Treatment

What You Will Learn

• Implementing the latest guidelines for managing Dyslipidemia (LDL) when caring for patients with elevated lipid levels with or without other comorbidities (or LDL syndromes).
• Examining how advanced lipid-management care plans may affect overall treatment for patients with LDL.
• Identifying the roles and responsibilities of the cardiology interprofessional care team when managing patients with LDL in various settings.

We are grateful to these distinguished faculty who contributed to this collection:

Chair

Eugenia Gianos MD, FACC
Joseph Ebinger, MD, FACC

Faculty

Alexander C. Razavi MD, MPH, PHD
Ashley A. Waring MD, FACC
Bruce Warden PharmD, BCPS, CLS, FNLA, FASPC
Catherine P Benziger MD, MPH, FACC
Carlos A. Vergara Sanchez MD
John Wilkins MD
Laura J. Ross PA-C, AACC
Maxima Mendez MD, FACC
Maya Safarova MD, FACC
Michael J. Blaha MD, MPH
Nishant P. Shah MD, FACC
Pamela B. Morris MD, FACC
Roger S. Blumenthal MD, FACC
Romit Bhattacharya MD, FACC
Ron Blankstein MD, FACC
Salim S. Virani MD, FACC
Samuel Kim MD, FACC
Seth S. Martin MD MHS, FACC
Ty J. Gluckman MD, FACC

Educational Grant Support Provided By: Merck & Co, and Eli Lilly and Company

Page Launched: September 2026